Učitavanje...
Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression()()
Our group has previously reported that the majority of human melanomas (> 60%) express the metabotropic glutamate receptor 1 (GRM1) and that the glutamate release inhibitor riluzole, a drug currently used to treat amyotrophic lateral sclerosis, can induce apoptosis in GRM1-expressing melanoma cel...
Spremljeno u:
| Izdano u: | Transl Oncol |
|---|---|
| Glavni autori: | , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Neoplasia Press
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4350641/ https://ncbi.nlm.nih.gov/pubmed/25749171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2014.11.001 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|